|
Total properties:
58
|
|
|
|
Patent #:
|
|
Issue Dt:
|
03/02/2010
|
Application #:
|
10416424
|
Filing Dt:
|
10/22/2003
|
|
Publication #:
|
|
Pub Dt:
|
06/10/2004
| | | | |
|
Title:
|
USE OF MUTAGENIC DNA POLYMERASE FOR PRODUCING RANDOM MUTATIONS
|
|
|
|
|
Patent #:
|
|
Issue Dt:
|
03/05/2013
|
Application #:
|
10552314
|
Filing Dt:
|
09/05/2006
|
|
Publication #:
|
|
Pub Dt:
|
02/15/2007
| | | | |
|
Title:
|
STABILISING FORMULATION FOR IMMUNOGLOBULIN G COMPOSITIONS IN LIQUID FORM AND IN LYOPHILISED FORM
|
|
|
|
|
Patent #:
|
|
Issue Dt:
|
06/01/2010
|
Application #:
|
10563620
|
Filing Dt:
|
06/19/2006
|
|
Publication #:
|
|
Pub Dt:
|
11/02/2006
| | | | |
|
Title:
|
METHOD FOR STABILIZING A CRYOPRECIPITATE OF PLASMATIC PROTEINS FOR BEING SUBJECTED TO A VIRAL INACTIVATION THERMAL TREATMENT
|
|
|
|
|
Patent #:
|
|
Issue Dt:
|
05/11/2010
|
Application #:
|
10566358
|
Filing Dt:
|
04/13/2006
|
|
Publication #:
|
|
Pub Dt:
|
08/17/2006
| | | | |
|
Title:
|
USE OF ADCC-OPTIMIZED ANTIBODIES FOR TREATING LOW-RESPONDER PATIENTS
|
|
|
|
|
Patent #:
|
|
Issue Dt:
|
04/26/2011
|
Application #:
|
10576794
|
Filing Dt:
|
05/24/2007
|
|
Publication #:
|
|
Pub Dt:
|
11/29/2007
| | | | |
|
Title:
|
VIRALLY-SAFE FACTOR VIII WITH A LOW CONTENT OF HIGHER MULTIMERS
|
|
|
|
|
Patent #:
|
|
Issue Dt:
|
12/03/2013
|
Application #:
|
11477212
|
Filing Dt:
|
06/28/2006
|
|
Publication #:
|
|
Pub Dt:
|
08/28/2008
| | | | |
|
Title:
|
Process for separating proteins fibrinogen, factor XIII and biological glue from a solubilized plasma fraction and for preparing lyophilised concentrates of said proteins
|
|
|
|
|
Patent #:
|
|
Issue Dt:
|
01/12/2016
|
Application #:
|
11793138
|
Filing Dt:
|
08/14/2008
|
|
Publication #:
|
|
Pub Dt:
|
02/26/2009
| | | | |
|
Title:
|
A MONOCLONAL ANTIBODY DIRECTED AGAINST CD20 ANTIGEN
|
|
|
|
|
Patent #:
|
|
Issue Dt:
|
08/28/2012
|
Application #:
|
12097860
|
Filing Dt:
|
09/24/2008
|
|
Publication #:
|
|
Pub Dt:
|
12/03/2009
| | | | |
|
Title:
|
THE INVENTION RELATES TO A METHOD OF VIRAL INACTIVATION BY DRY HEATING
|
|
|
|
|
Patent #:
|
|
Issue Dt:
|
04/10/2012
|
Application #:
|
12159199
|
Filing Dt:
|
11/05/2008
|
|
Publication #:
|
|
Pub Dt:
|
03/19/2009
| | | | |
|
Title:
|
IMMUNOGLOBULIN G (IGG) CONCENTRATE DEPLETED OF ANTI-A AND ANTI-B ANTIBODIES AND OF POLYREACTIVE IGGS
|
|
|
|
|
Patent #:
|
|
Issue Dt:
|
07/09/2019
|
Application #:
|
12300486
|
Filing Dt:
|
04/20/2009
|
|
Publication #:
|
|
Pub Dt:
|
12/17/2009
| | | | |
|
Title:
|
RECOMBINANT OR TRANSGENIC FACTOR VII COMPOSITION, EACH FACTOR VII MOLECULE HAVING TWO N-GLYCOSYLATION SITES WITH DEFINED GLYCAN UNITS
|
|
|
|
|
Patent #:
|
|
Issue Dt:
|
08/06/2013
|
Application #:
|
12659824
|
Filing Dt:
|
03/23/2010
|
|
Publication #:
|
|
Pub Dt:
|
12/02/2010
| | | | |
|
Title:
|
Use of ADCC-Optimized antibodies for treating weak patients
|
|
|
|
|
Patent #:
|
|
Issue Dt:
|
06/03/2014
|
Application #:
|
13257502
|
Filing Dt:
|
09/19/2011
|
|
Publication #:
|
|
Pub Dt:
|
01/12/2012
| | | | |
|
Title:
|
OPTIMIZED FC VARIANTS
|
|
|
|
|
Patent #:
|
|
Issue Dt:
|
05/12/2015
|
Application #:
|
13377680
|
Filing Dt:
|
12/12/2011
|
|
Publication #:
|
|
Pub Dt:
|
04/12/2012
| | | | |
|
Title:
|
FACTOR VII COMPOSITION
|
|
|
|
|
Patent #:
|
|
Issue Dt:
|
11/29/2016
|
Application #:
|
13510553
|
Filing Dt:
|
07/24/2012
|
|
Publication #:
|
|
Pub Dt:
|
06/06/2013
| | | | |
|
Title:
|
METHOD FOR TREATING BLOOD PLASMA INCLUDING A STEP OF WASHING BY MEANS OF DISPERSION
|
|
|
|
|
Patent #:
|
|
Issue Dt:
|
11/11/2014
|
Application #:
|
13583337
|
Filing Dt:
|
12/03/2012
|
|
Publication #:
|
|
Pub Dt:
|
05/16/2013
| | | | |
|
Title:
|
NOVEL SIGNAL PEPTIDE, AND USE THEREOF FOR PRODUCING RECOMBINANT PROTEINS
|
|
|
|
|
Patent #:
|
|
Issue Dt:
|
07/29/2014
|
Application #:
|
13695820
|
Filing Dt:
|
11/02/2012
|
|
Publication #:
|
|
Pub Dt:
|
02/28/2013
| | | | |
|
Title:
|
METHOD FOR MEASURING IGG-MEDIATED COMPLEMENT ACTIVATION
|
|
|
|
|
Patent #:
|
|
Issue Dt:
|
10/11/2016
|
Application #:
|
13752189
|
Filing Dt:
|
01/28/2013
|
|
Publication #:
|
|
Pub Dt:
|
08/08/2013
| | | | |
|
Title:
|
METHOD FOR STABILISING AN IMMUNOGLOBULIN G COMPOSITION IN LIQUID FORM
|
|
|
|
|
Patent #:
|
|
Issue Dt:
|
07/30/2019
|
Application #:
|
13886033
|
Filing Dt:
|
05/02/2013
|
|
Publication #:
|
|
Pub Dt:
|
04/03/2014
| | | | |
|
Title:
|
RECOMBINANT OR TRANSGENIC FACTOR VII COMPOSITION, EACH FACTOR VII MOLECULE HAVING TWO N-GLYCOSYLATION SITES WITH DEFINED GLYCAN UNITS
|
|
|
|
|
Patent #:
|
|
Issue Dt:
|
08/18/2015
|
Application #:
|
13930070
|
Filing Dt:
|
06/28/2013
|
|
Publication #:
|
|
Pub Dt:
|
01/16/2014
| | | | |
|
Title:
|
USE OF ADCC-OPTIMIZED ANTIBODIES FOR TREATING WEAK PATIENTS
|
|
|
|
|
Patent #:
|
|
Issue Dt:
|
01/17/2023
|
Application #:
|
13994207
|
Filing Dt:
|
07/23/2013
|
|
Publication #:
|
|
Pub Dt:
|
12/05/2013
| | | | |
|
Title:
|
GLYCOLS AS PATHOGEN INACTIVATING AGENTS
|
|
|
|
|
Patent #:
|
|
Issue Dt:
|
05/17/2016
|
Application #:
|
14056886
|
Filing Dt:
|
10/17/2013
|
|
Publication #:
|
|
Pub Dt:
|
05/29/2014
| | | | |
|
Title:
|
PROCESS FOR SEPARATING PROTEINS FIBRINOGEN, FACTOR XIII AND BIOLOGICAL GLUE FROM A SOLUBILIZED PLASMA FRACTION AND FOR PREPARING LYOPHILISED CONCENTRATES OF SAID PROTEINS
|
|
|
|
|
Patent #:
|
|
Issue Dt:
|
04/26/2016
|
Application #:
|
14056903
|
Filing Dt:
|
10/17/2013
|
|
Publication #:
|
|
Pub Dt:
|
06/05/2014
| | | | |
|
Title:
|
PROCESS FOR SEPARATING PROTEINS FIBRINOGEN, FACTOR XIII AND BIOLOGICAL GLUE FROM A SOLUBILIZED PLASMA FRACTION AND FOR PREPARING LYOPHILISED CONCENTRATES OF SAID PROTEINS
|
|
|
|
|
Patent #:
|
|
Issue Dt:
|
11/10/2015
|
Application #:
|
14112175
|
Filing Dt:
|
10/16/2013
|
|
Publication #:
|
|
Pub Dt:
|
02/13/2014
| | | | |
|
Title:
|
METHOD FOR PREPARING A CONCENTRATE OF FACTOR XI
|
|
|
|
|
Patent #:
|
|
Issue Dt:
|
05/03/2016
|
Application #:
|
14338413
|
Filing Dt:
|
07/23/2014
|
|
Title:
|
OPTIMIZED FC VARIANTS
|
|
|
|
|
Patent #:
|
|
Issue Dt:
|
02/13/2018
|
Application #:
|
14343642
|
Filing Dt:
|
06/23/2014
|
|
Publication #:
|
|
Pub Dt:
|
10/02/2014
| | | | |
|
Title:
|
DETERMINATION OF THE THROMBOGENIC POWER OF HUMAN IMMUNOGLOBULINS
|
|
|
|
|
Patent #:
|
|
Issue Dt:
|
01/24/2017
|
Application #:
|
14354331
|
Filing Dt:
|
04/25/2014
|
|
Publication #:
|
|
Pub Dt:
|
08/28/2014
| | | | |
|
Title:
|
TRANSCRIPTION UNIT AND USE THEREOF IN EXPRESSION VECTORS
|
|
|
|
|
Patent #:
|
|
Issue Dt:
|
12/06/2016
|
Application #:
|
14375503
|
Filing Dt:
|
07/30/2014
|
|
Publication #:
|
|
Pub Dt:
|
03/12/2015
| | | | |
|
Title:
|
TRANSCRIPTION UNITS AND THE USE THEREOF IN EXPRESSION VECTORS
|
|
|
|
|
Patent #:
|
|
Issue Dt:
|
05/29/2018
|
Application #:
|
14415254
|
Filing Dt:
|
01/16/2015
|
|
Publication #:
|
|
Pub Dt:
|
06/25/2015
| | | | |
|
Title:
|
METHOD FOR PURIFYING TRANSGENIC FACTOR VII/VIIA
|
|
|
|
|
Patent #:
|
|
Issue Dt:
|
04/04/2017
|
Application #:
|
14611460
|
Filing Dt:
|
02/02/2015
|
|
Publication #:
|
|
Pub Dt:
|
06/04/2015
| | | | |
|
Title:
|
ALBUMIN-PURIFICATION METHOD COMPRISING A NANOFILTRATION STEP, SOLUTION, AND COMPOSITION FOR THERAPEUTIC USE CONTAINING THE SAME
|
|
|
|
|
Patent #:
|
|
Issue Dt:
|
06/07/2016
|
Application #:
|
14687499
|
Filing Dt:
|
04/15/2015
|
|
Publication #:
|
|
Pub Dt:
|
08/06/2015
| | | | |
|
Title:
|
FACTOR VII COMPOSITION
|
|
|
|
|
Patent #:
|
|
Issue Dt:
|
01/30/2018
|
Application #:
|
14702143
|
Filing Dt:
|
05/01/2015
|
|
Publication #:
|
|
Pub Dt:
|
10/29/2015
| | | | |
|
Title:
|
USE OF ADCC-OPTIMIZED ANTIBODIES FOR TREATING LOW-RESPONDER PATIENTS
|
|
|
|
|
Patent #:
|
NONE
|
Issue Dt:
|
|
Application #:
|
14767089
|
Filing Dt:
|
08/11/2015
|
|
Publication #:
|
|
Pub Dt:
|
01/07/2016
| | | | |
|
Title:
|
CETUXIMAB WITH MODIFIED GLYCOSYLATION AND USES THEREOF
|
|
|
|
|
Patent #:
|
|
Issue Dt:
|
01/23/2018
|
Application #:
|
14828177
|
Filing Dt:
|
08/17/2015
|
|
Publication #:
|
|
Pub Dt:
|
03/03/2016
| | | | |
|
Title:
|
AN ANTIBODY METHOD FOR TREATMENT OF A DISEASE IN WHICH THE TARGET CELLS ARE CELLS WHICH EXPRESS CD20
|
|
|
|
|
Patent #:
|
|
Issue Dt:
|
06/16/2020
|
Application #:
|
14896763
|
Filing Dt:
|
12/08/2015
|
|
Publication #:
|
|
Pub Dt:
|
06/02/2016
| | | | |
|
Title:
|
TRANSGENIC FACTOR VII HAVING A SPECIFIC N-GLYCOSYLATION AND SUBSTANTIALLY HOMOGENOUS ISOELECTRIC POINT
|
|
|
|
|
Patent #:
|
|
Issue Dt:
|
04/07/2020
|
Application #:
|
14902716
|
Filing Dt:
|
01/04/2016
|
|
Publication #:
|
|
Pub Dt:
|
06/16/2016
| | | | |
|
Title:
|
AFFINITY CHROMATOGRAPHY MATRIX
|
|
|
|
|
Patent #:
|
|
Issue Dt:
|
10/24/2017
|
Application #:
|
14993277
|
Filing Dt:
|
01/12/2016
|
|
Title:
|
OPTIMIZED FC VARIANTS
|
|
|
|
|
Patent #:
|
|
Issue Dt:
|
05/15/2018
|
Application #:
|
15165786
|
Filing Dt:
|
05/26/2016
|
|
Publication #:
|
|
Pub Dt:
|
09/22/2016
| | | | |
|
Title:
|
FACTOR VII COMPOSITION
|
|
|
|
|
Patent #:
|
|
Issue Dt:
|
02/18/2020
|
Application #:
|
15443884
|
Filing Dt:
|
02/27/2017
|
|
Publication #:
|
|
Pub Dt:
|
06/15/2017
| | | | |
|
Title:
|
ALBUMIN-PURIFICATION METHOD COMPRISING A NANOFILTRATION STEP, SOLUTION, AND COMPOSITION FOR THERAPEUTIC USE CONTAINING THE SAME
|
|
|
|
|
Patent #:
|
|
Issue Dt:
|
07/30/2019
|
Application #:
|
15508577
|
Filing Dt:
|
03/03/2017
|
|
Publication #:
|
|
Pub Dt:
|
09/28/2017
| | | | |
|
Title:
|
METHOD FOR PURIFICATION OF MONOCLONAL ANTIBODIES
|
|
|
|
|
Patent #:
|
|
Issue Dt:
|
05/16/2023
|
Application #:
|
15554022
|
Filing Dt:
|
08/28/2017
|
|
Publication #:
|
|
Pub Dt:
|
02/01/2018
| | | | |
|
Title:
|
FC MUTANTS WITH MODIFIED FUNCTIONAL ACTIVITY
|
|
|
|
|
Patent #:
|
|
Issue Dt:
|
03/26/2019
|
Application #:
|
15563046
|
Filing Dt:
|
09/29/2017
|
|
Publication #:
|
|
Pub Dt:
|
03/08/2018
| | | | |
|
Title:
|
Cell Line Overexpressing Human CD303 Antigen
|
|
|
|
|
Patent #:
|
|
Issue Dt:
|
08/16/2022
|
Application #:
|
15737469
|
Filing Dt:
|
12/18/2017
|
|
Publication #:
|
|
Pub Dt:
|
01/03/2019
| | | | |
|
Title:
|
METHOD FOR THE CRYOPRESERVATION OF CELLS FOR THERAPEUTIC PURPOSES
|
|
|
|
|
Patent #:
|
NONE
|
Issue Dt:
|
|
Application #:
|
15742268
|
Filing Dt:
|
01/05/2018
|
|
Publication #:
|
|
Pub Dt:
|
12/13/2018
| | | | |
|
Title:
|
USE OF MODIFIED FC FRAGMENTS IN IMMUNOTHERAPY
|
|
|
|
|
Patent #:
|
NONE
|
Issue Dt:
|
|
Application #:
|
16162735
|
Filing Dt:
|
10/17/2018
|
|
Publication #:
|
|
Pub Dt:
|
08/22/2019
| | | | |
|
Title:
|
GLYCOLS AS PATHOGEN INACTIVATING AGENTS
|
|
|
|
|
Patent #:
|
|
Issue Dt:
|
11/14/2023
|
Application #:
|
16315356
|
Filing Dt:
|
01/04/2019
|
|
Publication #:
|
|
Pub Dt:
|
10/10/2019
| | | | |
|
Title:
|
FC MUTANTS WITH IMPROVED FUNCTIONAL ACTIVITY
|
|
|
|
|
Patent #:
|
NONE
|
Issue Dt:
|
|
Application #:
|
16315388
|
Filing Dt:
|
01/29/2019
|
|
Publication #:
|
|
Pub Dt:
|
07/11/2019
| | | | |
|
Title:
|
STABLE LIQUID FIBRINOGEN
|
|
|
|
|
Patent #:
|
NONE
|
Issue Dt:
|
|
Application #:
|
16345620
|
Filing Dt:
|
04/26/2019
|
|
Publication #:
|
|
Pub Dt:
|
09/26/2019
| | | | |
|
Title:
|
FC POLYPEPTIDE VARIANTS HAVING AN INCREASED HALF-LIFE
|
|
|
|
|
Patent #:
|
NONE
|
Issue Dt:
|
|
Application #:
|
16697519
|
Filing Dt:
|
11/27/2019
|
|
Publication #:
|
|
Pub Dt:
|
10/22/2020
| | | | |
|
Title:
|
ORAL COMPOSITION OF ANTI-TNF ALPHA ANTIBODIES
|
|
|
|
|
Patent #:
|
|
Issue Dt:
|
10/17/2023
|
Application #:
|
16766900
|
Filing Dt:
|
05/26/2020
|
|
Publication #:
|
|
Pub Dt:
|
08/12/2021
| | | | |
|
Title:
|
Method for the Cryopreservation of Cells for Therapeutic Purposes
|
|
|
|
|
Patent #:
|
NONE
|
Issue Dt:
|
|
Application #:
|
16772244
|
Filing Dt:
|
06/12/2020
|
|
Publication #:
|
|
Pub Dt:
|
07/15/2021
| | | | |
|
Title:
|
VARIANTS WITH FC FRAGMENT HAVING AN INCREASED AFFINITY FOR FCRN AND AN INCREASED AFFINITY FOR AT LEAST ONE RECEPTOR OF THE FC FRAGMENT
|
|
|
|
|
Patent #:
|
|
Issue Dt:
|
02/22/2022
|
Application #:
|
16868803
|
Filing Dt:
|
05/07/2020
|
|
Publication #:
|
|
Pub Dt:
|
08/27/2020
| | | | |
|
Title:
|
Factor VII Composition Having a Substantially Homogenous Isoelectric Point
|
|
|
|
|
Patent #:
|
NONE
|
Issue Dt:
|
|
Application #:
|
16868850
|
Filing Dt:
|
05/07/2020
|
|
Publication #:
|
|
Pub Dt:
|
11/19/2020
| | | | |
|
Title:
|
Factor VII Composition Having a Substantially Homogeneous Isoelectric Point
|
|
|
|
|
Patent #:
|
NONE
|
Issue Dt:
|
|
Application #:
|
17056626
|
Filing Dt:
|
11/18/2020
|
|
Publication #:
|
|
Pub Dt:
|
07/08/2021
| | | | |
|
Title:
|
Composition of Concentrated Human Immunoglobulins
|
|
|
|
|
Patent #:
|
NONE
|
Issue Dt:
|
|
Application #:
|
17251695
|
Filing Dt:
|
12/11/2020
|
|
Publication #:
|
|
Pub Dt:
|
05/19/2022
| | | | |
|
Title:
|
COMBINATION OF FACTOR VII AND AN ANTI-FACTOR IX/X BISPECIFIC ANTIBODY
|
|
|
|
|
Patent #:
|
NONE
|
Issue Dt:
|
|
Application #:
|
17293867
|
Filing Dt:
|
05/13/2021
|
|
Publication #:
|
|
Pub Dt:
|
07/21/2022
| | | | |
|
Title:
|
METHOD OF PRESERVING CELLS FOR THERAPEUTIC USE
|
|
|
|
|
Patent #:
|
NONE
|
Issue Dt:
|
07/02/2024
|
Application #:
|
17297504
|
Filing Dt:
|
05/27/2021
|
|
Publication #:
|
|
Pub Dt:
|
02/03/2022
| | | | |
|
Title:
|
SAMPLING DEVICE FOR SAMPLING FROM A SURFACE OF AN INDUSTRIAL VESSEL WITHOUT REQUIRING A PERSON TO DESCEND INTO AN INDUSTRIAL VESSEL, USING A SWAB
|
|
|
|
|
Patent #:
|
NONE
|
Issue Dt:
|
|
Application #:
|
17389878
|
Filing Dt:
|
07/30/2021
|
|
Publication #:
|
|
Pub Dt:
|
03/31/2022
| | | | |
|
Title:
|
Method for Obtaining Aptamers
|
|
|
|
|
Patent #:
|
NONE
|
Issue Dt:
|
|
Application #:
|
17416143
|
Filing Dt:
|
06/18/2021
|
|
Publication #:
|
|
Pub Dt:
|
02/24/2022
| | | | |
|
Title:
|
Method for Filtering Fibrinogen
|
|
